Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-May-08 6:23 PM View:  | Westphal Christoph H President and CEO Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-08 | Option Exercise | 181,796 | $0.72 | $131,456.00 | 32% 562.26K to 744.05K | 3007% |
| 30-May-08 6:24 PM View: | Brannelly Paul VP Finance, Treasurer | Sirtris Pharmaceuticals, Inc. (SIRT) | 28-May-08 | Option Exercise | 14,643 | $0.42 | $6,150.06 | 86% 17.0K to 31.64K | 5250% |
| 30-May-08 6:23 PM View: | Elliott Peter Senior VP, Head of Development | Sirtris Pharmaceuticals, Inc. (SIRT) | 27-May-08 | Option Exercise | 95,832 | $0.57 | $54,820.50 | 69% 138.79K to 234.62K | 3828% |
| 15-Apr-08 5:50 PM View: | Sinclair David Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 11-Apr-08 | Market Sale (Planned) | 7,971 | $13.10 | $104,436.00 | (5%) 162.93K to 154.96K | (70%) |
| 15-Apr-08 5:48 PM View: | Sinclair David Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 11-Apr-08 | Market Sale (Planned) | 2,129 | $13.42 | $28,570.60 | (1%) 154.96K to 152.83K | (66%) |
| 14-Apr-08 12:14 PM View: | Sinclair David Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 10-Apr-08 | Market Sale (Planned) | 9,900 | $13.27 | $131,380.00 | (6%) 172.83K to 162.93K | (68%) |
| 07-Mar-08 11:41 AM View: | Westphal Christoph H President and CEO Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 05-Mar-08 | Market Sale (Planned) | 6,810 | $11.53 | $78,498.70 | (1%) 569.07K to 562.26K | (125%) |
| 06-Mar-08 3:16 PM View: | Westphal Christoph H President and CEO Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 04-Mar-08 | Market Sale (Planned) | 8,690 | $11.53 | $100,154.00 | (< 1%) 1.15M to 1.14M | (125%) |
| 26-Feb-08 4:10 PM View: | Brannelly Paul VP Finance, Treasurer | Sirtris Pharmaceuticals, Inc. (SIRT) | 22-Feb-08 | Grant | 5,000 | -- | -- | 42% 12.0K to 17.0K | |
| 22-Feb-08 12:23 PM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 20-Feb-08 | Market Sale (Planned) | 12,800 | $11.44 | $146,375.00 | (26%) 49.5K to 36.7K | (1%) |
| 22-Feb-08 12:23 PM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 20-Feb-08 | Grant | 17,000 | $1.10 | $18,700.00 | 52% 32.5K to 49.5K | |
| 22-Feb-08 12:22 PM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 20-Feb-08 | Market Sale (Planned) | 4,200 | $11.63 | $48,839.00 | (11%) 36.7K to 32.5K | < 1% |
| 08-Feb-08 4:47 PM View: | Brannelly Paul VP Finance, Treasurer | Sirtris Pharmaceuticals, Inc. (SIRT) | 06-Feb-08 | Market Sale (Planned) | 6,547 | $12.29 | $80,438.40 | (35%) 18.55K to 12.0K | 6% |
| 28-Jan-08 4:51 PM View: | Brannelly Paul VP Finance, Treasurer | Sirtris Pharmaceuticals, Inc. (SIRT) | 24-Jan-08 | Market Sale (Planned) | 6,548 | $12.92 | $84,588.90 | (26%) 25.09K to 18.55K | (100%) |
| 24-Jan-08 11:57 AM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 22-Jan-08 | Grant | 20,000 | $1.10 | $22,000.00 | 62% 32.5K to 52.5K | |
| 24-Jan-08 11:57 AM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 22-Jan-08 | Market Sale (Planned) | 10,671 | $12.58 | $134,264.00 | (25%) 43.55K to 32.88K | (106%) |
| 24-Jan-08 11:58 AM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 22-Jan-08 | Market Sale (Planned) | 382 | $13.04 | $4,980.74 | (1%) 32.88K to 32.5K | (99%) |
| 24-Jan-08 11:57 AM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 22-Jan-08 | Market Sale (Planned) | 8,947 | $12.34 | $110,373.00 | (17%) 52.5K to 43.55K | (110%) |
| 14-Jan-08 4:26 PM View: | Sinclair David Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 10-Jan-08 | Market Sale (Planned) | 10,000 | $13.87 | $138,704.00 | (5%) 182.83K to 172.83K | (87%) |
| 10-Jan-08 4:53 PM View: | Westphal Christoph H President and CEO Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 08-Jan-08 | Market Sale (Planned) | 19,813 | $13.47 | $266,875.00 | (3%) 617.76K to 597.94K | (92%) |
| 10-Jan-08 4:54 PM View: | Westphal Christoph H President and CEO Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 08-Jan-08 | Market Sale (Planned) | 20,187 | $14.25 | $287,732.00 | (3%) 597.94K to 577.76K | (82%) |
| 04-Jan-08 3:49 PM View: | Bohlin Garen G COO and Assistant Secretary | Sirtris Pharmaceuticals, Inc. (SIRT) | 02-Jan-08 | Grant | 55,000 | -- | -- | 100% 0 to 55.0K | |
| 04-Jan-08 3:46 PM View: | Brannelly Paul VP Finance, Treasurer | Sirtris Pharmaceuticals, Inc. (SIRT) | 02-Jan-08 | Grant | 12,000 | -- | -- | 92% 13.1K to 25.09K | |
| 04-Jan-08 3:50 PM View: | Jirousek Michael Senior VP, Research | Sirtris Pharmaceuticals, Inc. (SIRT) | 02-Jan-08 | Grant | 32,500 | -- | -- | 100% 0 to 32.5K | |
| 04-Dec-07 10:41 AM View: | Schimmel Paul Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 30-Nov-07 | Option Exercise | 26,785 | $0.42 | $11,249.70 | 8% 325.24K to 352.02K | |
| 04-Dec-07 10:41 AM View: | Schimmel Paul Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 30-Nov-07 | Market Option Sale | 11,503 | $17.00 | $195,566.00 | (3%) 352.02K to 340.52K | (52%) |
| 04-Dec-07 6:47 PM View: | Polaris Venture Management ... 10% Owner | Sirtris Pharmaceuticals, Inc. (SIRT) | 30-Nov-07 | Disposition (other) | 1,000,000 | -- | -- | (31%) 3.25M to 2.25M | |
| 31-May-07 3:39 PM View: | Schimmel Paul Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 266,666 | -- | -- | 455% 58.57K to 325.24K | |
| 31-May-07 3:37 PM View: | Freund John Gordon Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion Duplicate | 1,846,140 | -- | -- | 100% 0 to 1.85M | |
| 31-May-07 3:36 PM View: | Hoffman Stephen J Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 1,846,140 | -- | -- | 100% 0 to 1.85M | |
| 31-May-07 3:35 PM View: | Westphal Christoph H President and CEO Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 2,834 | -- | -- | < 1% 464.92K to 467.76K | |
| 30-May-07 4:52 PM View: | Polaris Venture Management ... 10% Owner | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 3,067,530 | -- | -- | 1695% 180.95K to 3.25M | |
| 31-May-07 3:36 PM View: | Elliott Peter Senior VP, Head of Development | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 2,834 | -- | -- | 3% 93.45K to 96.29K | |
| 30-May-07 4:48 PM View: | Tvm V Life Science Ventures... 10% Owner | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 2,577,440 | -- | -- | 100% 0 to 2.58M | |
| 31-May-07 3:38 PM View: | Sinclair David Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 12,358 | -- | -- | 8% 150.48K to 162.83K | |
| 31-May-07 3:39 PM View: | Clarke John K Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 2,073,470 | -- | -- | 100% 0 to 2.07M | |
| 31-May-07 3:37 PM View: | Aldrich Richard Director | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 38,095 | -- | -- | 100% 0 to 38.09K | |
| 13-Jun-07 1:34 PM View: | Henry John William 10% Owner | Sirtris Pharmaceuticals, Inc. (SIRT) | 22-May-07 | Conversion | 2,267,570 | -- | -- | 100% 0 to 2.27M |
